Nov 24 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday that two late-stage trials testing an older oral version of its semaglutide drug failed to meet their main goal. Shares in Novo ...
Dementia is a leading cause of disability and dependency among seniors globally. It is also the seventh leading cause of death. While the most common cause of dementia is Alzheimer’s disease (AD), ...
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease. The research, led by the University of Exeter, is published in Alzheimer's ...
Here’s what you’ll learn when you read this story: Treating Alzheimer’s requires a multi-faceted approach that can target various mechanisms behind this pernicious neurodegenerative disease. In a new ...
New research suggests that taking 3,000 steps or more a day can lower the risk of cognitive decline, even in people who are high risk. More steps had even greater benefits. Researchers discovered that ...
Even small amounts of walking could slow down the brain changes that lead to Alzheimer’s, a new study shows. In fact, results point to a very specific window where benefits peak. Researchers from Mass ...
During National Alzheimer’s Disease Awareness Month, we recognize the immense toll this devastating illness takes on millions of Americans and the families, friends, and caregivers who love and care ...
Another Week, Another Grand Jury Declines to Indict Letitia James The Land of Lincoln, and Home State of the Pope, Opts for Suicide A lot of observers of the Supreme Court oral argument last week in ...
Scientists have achieved a “striking” reversal of Alzheimer’s disease in mice by restoring the normal function of the brain's vasculature—the network of blood vessels that supplies it with oxygen and ...
In 2021, 57 million people across the planet were living with dementia. This class of memory-related diseases is the world’s seventh greatest killer, and Alzheimer’s disease is its most common form.
This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. Alzheimer’s disease has proved to be a ...
Few diagnoses carry the devastating weight of dementia, which heralds loss, decline and inevitable death. The condition is the biggest killer in the UK, and cases are set to soar. “One in three people ...